Campbell & Co Investment Adviser’s Celgene Corp CELG Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,161	Closed	-$283K	–	588
2018 Q3	$283K	Sell	3,161 -1,800	-36%	-$159K	0.19%	245
2018 Q2	$394K	Buy	4,961 +2,300	+86%	+$191K	0.3%	111
2018 Q1	$237K	Sell	2,661 -3,900	-59%	-$374K	0.2%	248
2017 Q4	$685K	Buy	+6,561	New	+$740K	0.51%	28
2016 Q4	–	Sell	-4,834	Closed	-$505K	–	243
2016 Q3	$505K	Buy	+4,834	New	+$523K	1.36%	10
2015 Q2	–	Sell	-12,757	Closed	-$1.47M	–	296
2015 Q1	$1.47M	Buy	+12,757	New	+$1.52M	0.93%	28
2014 Q2	–	Sell	-3,800	Closed	-$265K	–	305
2014 Q1	$265K	Sell	3,800 -10,626	-74%	-$841K	0.11%	176
2013 Q4	$1.22M	Buy	+14,426	New	+$1.14M	0.27%	114

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Campbell & Co Investment Adviser's CELG Position: Q4 2018 in Review

Campbell & Co Investment Adviser sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 3,161 shares — an estimated $283K sold.

Campbell & Co Investment Adviser first reported a position in CELG in Q4 2013 and held it in 8 quarters. The position peaked at $1.47M in Q1 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Campbell & Co Investment Adviser reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Campbell & Co Investment Adviser sold 3,161 Celgene Corp shares in Q4 2018, an estimated $283K.
Campbell & Co Investment Adviser first reported a position in Celgene Corp in Q4 2013 and held it in 8 quarters.
Campbell & Co Investment Adviser's Celgene Corp position peaked at $1.47M in Q1 2015.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2018, filed 8 Feb 2019.